Gene therapy shows promise in tackling X-linked RP
Early results from clinical testing of a gene therapy to treat X-linked retinitis pigmentosa (XLRP) have shown partial reversal of sight loss in some patients.
Search
Search results
The 5K Wight White Cane Walk 2025
Join Colin and Linda McArthur for their annual Isle of Wight walk, in aid of Retina UK's 50th anniversary.
About Unlock Genetics
The aim of the site is to increase the level of awareness and understanding of genetic testing and genetic counselling among people living with inherited retinal dystrophies, empowering them to make fully informed decisions about their lives, healthcare and family planning.
Hope To Seaview 2024
Join Colin & Linda McArthur for their annual Isle of Wight walk in support of Retina UK. Last year's event raised a record-breaking £6,000+!
Tyne & Wear Local Peer Support Group
Saturday 28 June, 1.00pm - 7.00pm - In-person - Come and join Colin Hetherington and the group for their latest social event at the Tyneside Irish Centre in Newcastle.
Our staff
We employ a number of full and part-time staff. Our office is in Buckingham.
What we do
Our vision is a world where everyone with inherited sight loss is able to live a fulfilling life.
Meira GTx announces positive data from phase clinical trial
Biotechnology company MeiraGTx has announced encouraging news from its phase 1/2 clinical trial of botaretigene sparoparvovec (previously known as AAV-RPGR), a gene therapy aimed at X-linked retinitis pigmentosa caused by faults in the RPGR gene.
Types of genetic testing
This page explains the different types of genetic tests: diagnostic testing, predictive testing, carrier testing and research testing
Quiz for Retina UK
Do you know your facts from your fiction? Host a quiz for Retina UK and raise vital funds for our ground-breaking work.